Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 11 studies | 23% ± 8% | |
brain | 9 studies | 35% ± 19% | |
peripheral blood | 7 studies | 25% ± 11% | |
eye | 4 studies | 24% ± 12% | |
liver | 4 studies | 30% ± 13% | |
placenta | 3 studies | 23% ± 1% | |
bone marrow | 3 studies | 20% ± 4% | |
adipose | 3 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 6303.30 | 459 / 459 | 100% | 166.18 | 1118 / 1118 |
esophagus | 100% | 5798.15 | 1445 / 1445 | 100% | 125.29 | 183 / 183 |
lung | 100% | 7994.68 | 578 / 578 | 100% | 127.95 | 1155 / 1155 |
uterus | 100% | 8031.98 | 170 / 170 | 100% | 118.75 | 459 / 459 |
bladder | 100% | 6721.33 | 21 / 21 | 100% | 143.35 | 503 / 504 |
ovary | 100% | 17219.83 | 180 / 180 | 100% | 83.97 | 429 / 430 |
liver | 100% | 5071.08 | 226 / 226 | 100% | 83.60 | 405 / 406 |
prostate | 100% | 6647.78 | 245 / 245 | 100% | 133.35 | 500 / 502 |
thymus | 100% | 7773.10 | 653 / 653 | 100% | 120.55 | 602 / 605 |
pancreas | 100% | 5496.82 | 328 / 328 | 99% | 108.36 | 177 / 178 |
intestine | 100% | 6598.42 | 966 / 966 | 99% | 170.26 | 524 / 527 |
stomach | 100% | 5749.96 | 359 / 359 | 99% | 158.87 | 284 / 286 |
brain | 98% | 3549.59 | 2602 / 2642 | 100% | 73.15 | 704 / 705 |
kidney | 100% | 5255.94 | 89 / 89 | 98% | 85.97 | 882 / 901 |
skin | 100% | 8118.41 | 1808 / 1809 | 97% | 115.07 | 459 / 472 |
adrenal gland | 100% | 8633.64 | 258 / 258 | 97% | 71.08 | 223 / 230 |
blood vessel | 100% | 8695.18 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 95.66 | 29 / 29 |
muscle | 100% | 5901.29 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 6811.43 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 103.19 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 43.89 | 1 / 1 |
adipose | 100% | 6744.83 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 98% | 5561.86 | 843 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 6005.84 | 862 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 91% | 54.61 | 73 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006986 | Biological process | response to unfolded protein |
GO_0018279 | Biological process | protein N-linked glycosylation via asparagine |
GO_0006487 | Biological process | protein N-linked glycosylation |
GO_0043687 | Biological process | post-translational protein modification |
GO_0036503 | Biological process | ERAD pathway |
GO_0043686 | Biological process | co-translational protein modification |
GO_0006516 | Biological process | glycoprotein catabolic process |
GO_0032991 | Cellular component | protein-containing complex |
GO_0008250 | Cellular component | oligosaccharyltransferase complex |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0034998 | Cellular component | oligosaccharyltransferase I complex |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0004579 | Molecular function | dolichyl-diphosphooligosaccharide-protein glycotransferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | STT3B |
Protein name | Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18) (Source of immunodominant MHC-associated peptides homolog) |
Synonyms | SIMP |
Description | FUNCTION: Catalytic subunit of the oligosaccharyl transferase (OST) complex that catalyzes the initial transfer of a defined glycan (Glc(3)Man(9)GlcNAc(2) in eukaryotes) from the lipid carrier dolichol-pyrophosphate to an asparagine residue within an Asn-X-Ser/Thr consensus motif in nascent polypeptide chains, the first step in protein N-glycosylation . N-glycosylation occurs cotranslationally and the complex associates with the Sec61 complex at the channel-forming translocon complex that mediates protein translocation across the endoplasmic reticulum (ER). All subunits are required for a maximal enzyme activity. This subunit contains the active site and the acceptor peptide and donor lipid-linked oligosaccharide (LLO) binding pockets (By similarity). STT3B is present in a small subset of OST complexes and mediates both cotranslational and post-translational N-glycosylation of target proteins: STT3B-containing complexes are required for efficient post-translational glycosylation and while they are less competent than STT3A-containing complexes for cotranslational glycosylation, they have the ability to mediate glycosylation of some nascent sites that are not accessible for STT3A. STT3B-containing complexes also act post-translationally and mediate modification of skipped glycosylation sites in unfolded proteins. Plays a role in ER-associated degradation (ERAD) pathway that mediates ubiquitin-dependent degradation of misfolded endoplasmic reticulum proteins by mediating N-glycosylation of unfolded proteins, which are then recognized by the ERAD pathway and targeted for degradation. Mediates glycosylation of the disease variant AMYL-TTR 'Asp-38' of TTR at 'Asn-118', leading to its degradation . . |
Accessions | Q8TCJ2 ENST00000295770.4 |